• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年加强疫苗接种:影响接种率的因素。

Teenage booster vaccine: factors affecting uptake.

机构信息

Vaccine Preventable Disease Programme, Public Health Wales, Temple of Peace and Health, Cathays Park, Cardiff, Wales CF10 3NW, UK.

出版信息

J Public Health (Oxf). 2012 Dec;34(4):498-504. doi: 10.1093/pubmed/fds047. Epub 2012 Jun 18.

DOI:10.1093/pubmed/fds047
PMID:22711912
Abstract

BACKGROUND

The teenage booster of tetanus/diphtheria/polio vaccine is the final dose in the routine UK childhood schedule. It has the lowest uptake of all childhood vaccines in Wales and no Health Board (HB) has achieved 95% uptake. We examined the services used to deliver this vaccine across Wales in order to determine how to improve the national uptake rate.

METHODS

A cross-sectional survey of the systems used to deliver the vaccine in the 7 HBs in Wales and their 22 constituent local authorities. Routinely published quarterly and annual COVER report uptake data for each HB were used to compare system effectiveness.

RESULTS

The vaccine was either offered in school, in general practice or in both settings. Higher uptake rates were achieved with greater consistency in schools (76-81%) compared with general practice (5-74%), and when coordinated by the HB. When an option was available, most parents chose for their child to be vaccinated in school.

CONCLUSIONS

Higher uptake rates of the teenage booster were observed when it was given in school compared with general practice. The findings suggest that offering the teenage booster in schools in all areas of Wales may improve vaccine uptake.

摘要

背景

青少年破伤风、白喉和脊髓灰质炎疫苗加强剂是英国儿童常规免疫接种程序中的最后一剂疫苗。在威尔士,该疫苗的接种率是所有儿童疫苗中最低的,没有一个卫生局(HB)达到了 95%的接种率。我们调查了威尔士各地提供这种疫苗的服务,以确定如何提高全国的接种率。

方法

对威尔士 7 个卫生局及其 22 个组成地方当局使用的系统进行了横断面调查。使用每个卫生局定期公布的每季度和年度 COVER 报告接种数据来比较系统的有效性。

结果

疫苗可以在学校、一般实践或这两种环境中提供。在学校接种的接种率更高(76-81%),比在一般实践接种的接种率(5-74%)更一致,并且由卫生局协调时接种率更高。当有选择时,大多数家长选择让孩子在学校接种疫苗。

结论

与在一般实践接种相比,在学校接种青少年破伤风、白喉和脊髓灰质炎疫苗加强剂的接种率更高。这些发现表明,在威尔士所有地区的学校提供青少年破伤风、白喉和脊髓灰质炎疫苗加强剂可能会提高疫苗接种率。

相似文献

1
Teenage booster vaccine: factors affecting uptake.青少年加强疫苗接种:影响接种率的因素。
J Public Health (Oxf). 2012 Dec;34(4):498-504. doi: 10.1093/pubmed/fds047. Epub 2012 Jun 18.
2
Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.白喉-破伤风-无细胞百日咳疫苗和灭活脊髓灰质炎病毒疫苗,在4至6岁时单独或联合接种进行加强免疫。
Pediatr Infect Dis J. 2008 Apr;27(4):341-6. doi: 10.1097/INF.0b013e3181616180.
3
One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.全液体五组分无细胞百日咳、白喉、破伤风、灭活脊髓灰质炎、b型流感嗜血杆菌结合疫苗的一年期一级抗体持久性及加强免疫反应
Int J Infect Dis. 2007 Nov;11(6):488-95. doi: 10.1016/j.ijid.2007.01.006. Epub 2007 Mar 8.
4
Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children.比较不同初免儿童中作为第五次加强剂接种的无细胞百日咳疫苗的耐受性。
Vaccine. 2011 Jun 10;29(26):4373-7. doi: 10.1016/j.vaccine.2011.04.009. Epub 2011 Apr 22.
5
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.一项关于破伤风、白喉和无细胞百日咳(Tdap)疫苗与破伤风和白喉(Td)疫苗作为健康成年人加强针时的安全性和免疫原性的随机、双盲、非劣效性临床试验比较。
Vaccine. 2012 Aug 10;30(37):5464-71. doi: 10.1016/j.vaccine.2012.06.073. Epub 2012 Jul 6.
6
Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years.与单独的白喉破伤风无细胞百日咳疫苗(DTaP)和灭活脊髓灰质炎疫苗(IPV)相比,联合DTaP-IPV疫苗作为4-6岁健康儿童的学龄前加强剂量并与第二剂麻疹腮腺炎风疹疫苗(MMR)同时接种时的免疫原性和安全性。
Vaccine. 2006 Aug 28;24(35-36):6163-71. doi: 10.1016/j.vaccine.2006.04.001. Epub 2006 Apr 21.
7
Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.联合低抗原含量白喉-破伤风-无细胞百日咳和脊髓灰质炎疫苗(dTpa-IPV)用于成人加强免疫接种。
Vaccine. 2005 May 25;23(28):3657-67. doi: 10.1016/j.vaccine.2005.02.013.
8
Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.在健康婴儿中同时接种7价肺炎球菌结合疫苗(PCV7)与白喉-破伤风-无细胞百日咳-乙肝-灭活脊髓灰质炎疫苗/ b型流感嗜血杆菌结合疫苗(DTPa-HBV-IPV/Hib)的免疫原性、反应原性及安全性。
Vaccine. 2006 May 29;24(22):4727-36. doi: 10.1016/j.vaccine.2006.03.032. Epub 2006 Mar 24.
9
Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine.白喉、破伤风、无细胞百日咳、乙型肝炎和灭活脊髓灰质炎联合疫苗基础免疫程序及加强剂量的安全性和免疫原性
Scand J Infect Dis. 2006;38(5):350-6. doi: 10.1080/00365540500488857.
10
Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.在泰国儿童中,于生命第二年使用无细胞百日咳联合疫苗进行初免后,接种白百破-灭活脊髓灰质炎病毒疫苗//b型流感嗜血杆菌结合疫苗(百达生)加强针的免疫原性和安全性。
Southeast Asian J Trop Med Public Health. 2009 Mar;40(2):282-94.

引用本文的文献

1
Linking cohort data and Welsh routine health records to investigate children at risk of delayed primary vaccination.将队列数据与威尔士常规健康记录联系起来,以调查有延迟基础免疫风险的儿童。
Vaccine. 2022 Aug 12;40(34):5016-5022. doi: 10.1016/j.vaccine.2022.06.080. Epub 2022 Jul 13.
2
Mapping of the Covid-19 Vaccine Uptake Determinants From Mining Twitter Data.从挖掘推特数据映射新冠疫苗接种的决定因素
IEEE Access. 2021 Sep 24;9:134929-134944. doi: 10.1109/ACCESS.2021.3115554. eCollection 2021.
3
What school-level and area-level factors influenced HPV and MenACWY vaccine coverage in England in 2016/2017? An ecological study.
2016/2017 年,哪些学校和地区因素影响了英格兰 HPV 和 MenACWY 疫苗的覆盖率?一项生态学研究。
BMJ Open. 2019 Jul 11;9(7):e029087. doi: 10.1136/bmjopen-2019-029087.
4
Teenagers' understandings of and attitudes towards vaccines and vaccine-preventable diseases: a qualitative study.青少年对疫苗和疫苗可预防疾病的认识和态度:一项定性研究。
Vaccine. 2013 May 24;31(22):2543-50. doi: 10.1016/j.vaccine.2013.04.023. Epub 2013 Apr 18.